Albany Molecular Research, Inc. (AMRI.O)

AMRI.O on Nasdaq

9.06USD
18 Dec 2009
Price Change (% chg)

$0.24 (+2.72%)
Prev Close
$8.82
Open
$8.90
Day's High
$9.12
Day's Low
$8.85
Volume
174,518
Avg. Vol
73,490
52-wk High
$12.56
52-wk Low
$7.31

AMRI.O

Chart for AMRI.O

About

Albany Molecular Research, Inc., provides scientific services, technologies and products. The Company's core business consists of a fee-for-service contract services platform encompassing drug discovery, development and manufacturing, and a separate, stand-alone research and development division consisting of technology... (more)

Overall

Beta: 1.17
Market Cap (Mil.): $279.10
Shares Outstanding (Mil.): 31.64
Annual Dividend: 0.00
Yield (%): NA

Financials

  AMRI.O Industry Sector
P/E (TTM): 48.64 3.54 4.61
EPS (TTM): -65.28 -- --
ROI: 1.55 1.79 2.83
ROE: 1.69 2.40 3.59
view overview for:

US-RESEARCH/ (NON-S&P500)

GSI Technology Inc Baird Cuts to neutral from outperform --------------------------------------------------------------- ------------ Guess? Inc Wedbush Cuts price target to $19 from $24;

05 Dec 2008

STOCKS NEWS US-Option fear gauge stays at lofty levels

Stocks on the move [HOT-RTRS] Real-Time Equity news [E U]

05 Dec 2008

STOCKS NEWS US-BCE hasn't received offer for minority stake

Stocks on the move [HOT-RTRS] Real-Time Equity news [E U]

05 Dec 2008

STOCKS NEWS US-Markets pare losses, Nasdaq turns positive

Stocks on the move [HOT-RTRS] Real-Time Equity news [E U]

05 Dec 2008

STOCKS NEWS US-Baird downgrades 6 semiconductor companies

Stocks on the move [HOT-RTRS] Real-Time Equity news [E U]

05 Dec 2008

STOCKS NEWS US-GM down, Ford up on 2nd day of exec testimony

Stocks on the move [HOT-RTRS] Real-Time Equity news [E U]

05 Dec 2008

STOCKS NEWS US-Wall St sinks as job losses mount, Boeing drags

Stocks on the move [HOT-RTRS] Real-Time Equity news [E U]

05 Dec 2008

STOCKS NEWS US-Albany Molecular falls after downgrade

Stocks on the move [HOT-RTRS] Real-Time Equity news [E U]

05 Dec 2008

UPDATE 1-Jefferies downgrades Albany Molecular, shares down

Dec 5 (Reuters) - Jefferies & Co downgraded Albany Molecular Research Inc to "underperform" from "hold," citing a negative impact on the company as smaller biotech companies scale back on research and development projects, sending its shares down about 15 percent.

05 Dec 2008

US RESEARCH SUMMARY-Non-S&P 500 Nov 11 1650 GMT

Following is a summary of research actions on non-S&P 500

11 Nov 2008

  Earnings  vs    Estimates

view overview for: